| TGA Action ID |
RC-2026-RN-00032-1 |
| Type of Product |
Medicine |
| Product Name/Description |
BORTEZOMIB 2.7MG IN SYRINGE (TERUMO) FOR SUBCUTANEOUS USE
Batch: BB25108256
Expiry: 14/12/2025
ARTG: Exempt |
| ARTG Number |
|
| Unique Device Identifier (UDI) |
n/a |
| Action Type |
Recall |
| Action Level |
Hospital |
| Hazard Classification |
Class I |
| Reason for the Action |
The product was supplied with an incorrect dose. The dose ordered by the customer was for 1.7mg/1.7mL, however, the dose supplied was 2.7mg/2.7mL.
Given the nature of the product, this action was undertaken prior to TGA notification (Immediate Market Action as defined within the PRAC). |
| Instructions for Customers/Users |
The batch was distributed to the customer on 14/10/2025.
The dose supplied was not administered to the patient. The error was detected by the hospital when they received the product and the syringe was discarded.
For further information customers should contact their Key Account Manager. |
| Action Commencement Date |
15/01/2026 |
| Responsible Entity |
|
| Contact Information |
03 9565 4400 - Slade Health Head Office |